研究　業績　学会発表　国際学会　＞

学会発表／国際学会（2024年 2023年）

　　　　　　

1. Medical supply transport to evacuation shelters by drone: proposal of oita model using rendezvous points of air ambulance. Ishihara Y, Otsubo Y, Hayashi K, Kuranari M, Wakuda H, Oikawa I, Kai M, Yamamura Y, Tatsuta R, Tsukamoto N, Takenaka R, Kakimoto K, Itoh H, Abe R, Tokumaru O, Uemura N. American Society for Clinical Pharmacology and Therapeutics 2024 Annual Meeting (Colorado Springs, USA) 2024.3
2. Pharmacokinetic and pharmacodynamic relationships of intranasally administered and intramuscularly injected epinephrine. van Haarst A, Paglialunga S, Spirito MD, Lambart A, Hunt A, Vinks AA, Mizuno T, Tanaka R, Rance K, Dworaczyk D. American Society for Clinical Pharmacology and Therapeutics 2024 Annual Meeting (Colorado Springs, USA) 2024.3
3. Risk factors for teicoplanin-associated acute kidney injury in patients with hematological malignancies: focusing on concomitant use of tazobactam/piperacillin. Morinaga Y, Tanaka R, Tatsuta R, Takano K, Hashimoto T, Ogata M, Hiramatsu K, Itoh H. 16th congress of the European Association for Clinical Pharmacology and Therapeutics (Rotterdam,Netherlands) 2024.6
4. PK/PD modeling of amoxicillin/clavulanic acid in vitro effects on bacterial growth and killing and in vivo exposure evaluation in young pediatric patients. Tanaka R, Mizuno T, Dewedoff K, Peck C, Vinks AA. 22nd International Congress of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT) 2024 (Banff, Canada) 2024.9
5. Sensitive quantification of free lenvatinib using ultra-high performance liquid chromatography coupled to tandem mass spectrometry and assessment for clinical application. Sueshige Y, Shiraiwa K, Tanaka R, Saito T, Iwao M, Arakawa M, Endo M, Tatsuta R, Murakami K, Itoh H. 22nd International Congress of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT) 2024 (Banff, Canada) 2024.9
6. Physiologically based pharmacokinetic model of vedolizumab in adult patients with inflammatory bowel disease. Parikh S, Tanaka R, Irie K, Mizuno T. 15th Annual American Conference on Pharmacometrics (Phoenix, USA) 2024.11

　　　　　　

1. Positive correlation between organic anion transporter 1B function indicated by plasma concentration of coproporphyrin-I and blood concentration of cyclosporin A in real-world patients. Tanaka R, Watanabe T, Suzuki Y, Sato H, Negami J, Yoshijima C, Oda A, Ono H, Tatsuta R, Ohno K, Itoh H. American Society for Clinical Pharmacology and Therapeutics 2023 Annual Meeting (Atlanta, USA) 2023.3
2. Pharmacokinetic evaluation of tacrolimus extended release and tacrolimus immediate release combined with early steroid withdrawal in de novo kidney transplant recipients. Alloway RR, Tanaka R, Mizuno T, Vinks AA, Tremblay S, Yanqui E, Hames H, Govil A, Shields AR, Woodle ES. American Transplant Congress (ATC) 2023 (Philadelphia, USA) 2023.6
3. Evaluation of extended release and immediate release tacrolimus with early steroid withdrawal in de novo kidney transplants utilizing novel endpoints. Alloway RR, Shields AR, Tremblay S, Tanaka R, Mizuno T, Vinks AA, Christianson A, Cuffy M, Bumb S, Kremer J, Woodle ES. American Transplant Congress (ATC) 2023 (Philadelphia, USA) 2023.6
4. Impact of inflammation on intra-individual variation in trough voriconazole concentration in patients with hematological malignancies. Tanaka R, Maeda Y, Tatsuta R, Takano K, Hashimoto T, Ogata M, Hiramatsu K, Itoh H. 21st Congress of the International Association of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT) 2023 (Oslo, Norway) 2023.9
5. A comparison of free concentrations and fractions in vivo between unchanged form and active metabolite of itraconazole using UHPLC-MS/MS assay with equilibrium dialysis. Iwao M, Tanaka R, Suzuki Y, Hashimoto T, Tatsuta R, Hiramatsu K, Itoh H. 21st Congress of the International Association of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT) 2023 (Oslo, Norway) 2023.9